Effect of SARS-CoV-2 infection on anti-HLA antibodies and de novo donor specific antibodies incidence in lung transplant recipients
Authors:
- Andrea ZajacovaAZAndrea Zajacova
- Eliska DvorackovaEDEliska Dvorackova
- Luis Fernando Casas-MendezLCLuis Fernando Casas-Mendez
- Katerina VychytilovaKVKaterina Vychytilova
- Dmitry RakitaDRDmitry Rakita
- Lucie Valentova-BartakovaLVLucie Valentova-Bartakova
- Monika SvorcovaMSMonika Svorcova
- Antonij SlavcevASAntonij Slavcev
- Libor FilaLFLibor Fila
- Robert LischkeRLRobert Lischke
- Jan HavlinJHJan Havlin
- 21 October 2023
- journal article
- research article
- Published by Elsevier in Transplant Immunology
- Vol. 81, 101938
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- COVID-19 in lung transplant recipients: A multicenter studyAmerican Journal of Transplantation, 2022
- Association between SARS-CoV-2 infection and de novo HLA donor specific antibody production in lung transplant recipients: Single-center studyHuman Immunology, 2022
- Impact of COVID-19 on Lung Allograft and Clinical Outcomes in Lung Transplant Recipients: A Case-control StudyTransplantation, 2021
- Outcomes of COVID-19 in Solid Organ Transplant Recipients: A Propensity-matched Analysis of a Large Research NetworkTransplantation, 2021
- COVID-19 in Lung Transplant RecipientsTransplantation, 2020
- Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL/MpSlac-lpr miceActa Pharmacologica Sinica, 2015
- The use of mycophenolate mofetil in liver transplant recipientsExpert Opinion on Pharmacotherapy, 2003
- Mycophenolate mofetil and its mechanisms of actionImmunopharmacology, 2000